



Drug Class: Dual GIP and GLP-1 Receptor Agonist
Composition: Tirzepatide
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Subcutaneous Injection
British Dragon store offers Tirze-Pep by Dragon Pharma, a high-purity GLP-1 receptor agonist research peptide designed for scientific and laboratory studies. This research compound has been examined for its role in metabolic studies, glucose regulation, and peptide-based research applications.
Tirze-Pep, crafted by Dragon Pharma, is a research-grade GLP-1 receptor agonist peptide available in a 2 mL vial in lyophilized powder form. This peptide-based compound is studied in scientific research exploring GLP-1 receptor activation, metabolic regulation, and peptide interactions.
As a GLP-1 research peptide, Tirze-Pep is analyzed for its impact on energy balance, receptor pathways, and glucose metabolism in controlled laboratory settings.
Tirze-Pep has been examined in various scientific studies for its potential effects on:
✅ GLP-1 receptor activation & metabolic function
✅ Peptide-based research on glucose metabolism
✅ Energy balance & appetite regulation studies
✅ GLP-1 pathway interactions in laboratory settings
Although Tirze-Pep is not a performance-enhancing substance, it is studied in metabolic research for its role in GLP-1 receptor activation. In hypothetical research applications, a 2 mL vial may be used over several weeks, with dosages adjusted based on laboratory study parameters.
Some research suggests mild and temporary effects such as:
✔ Nausea or mild digestive discomfort
✔ Injection site irritation
✔ Changes in appetite modulation
✔ Store in a cool, dry place away from direct sunlight
✔ Reconstitute using bacteriostatic water following standard peptide protocols
✔ For scientific research use only
✔ High-Purity GLP-1 Research Peptide
✔ Manufactured Under Strict Laboratory Conditions
✔ Verified Lab-Tested Quality
✔ Secure Ordering & Fast USA Shipping
⚠️ For research use only. Not for human consumption.
⚠️ This product is not approved for medical use, diagnosis, or treatment.
⚠️ Not affiliated with or manufactured by any pharmaceutical company.
Name: Tirze-Pep
Active Life: Approximately 5 days
Drug Class: Dual GIP and GLP-1 receptor agonist
Detection Time: Not applicable as it is not commonly included in standard drug testing protocols
Chemical Structure: C225H348N48O68
Common Doses: Starts at 2.5 mg once weekly; titrated up to 5 mg, 10 mg, or 15 mg once weekly based on clinical response and tolerability
Blood pressure: May help reduce blood pressure in patients
Acne: No
Water retention: Minimal to none
Aromatisation: No
Liver toxicity: No direct hepatotoxicity reported, but should be used with caution in patients with hepatic impairment
Decrease HPTA function: No
No. Ozempic contains semaglutide, a GLP-1 agonist, while tirzepatide is a dual GIP and GLP-1 agonist, offering more potent weight loss and glycemic effects.
Some users may experience nausea, fatigue, or constipation, especially during the initial dosing period. Gradual titration helps minimize side effects.
In clinical trials, it is often referred to under various brand names when used for diabetes. However, it is also studied for weight loss under the SURMOUNT program.
Appetite suppression typically begins within the first week. Visible fat loss is usually noticeable after 3–4 weeks with proper diet and activity.
Yes. Bodybuilders use tirzepatide during contest prep or cutting phases to suppress appetite, enhance insulin sensitivity, and maintain lean muscle.
Please log in to write Tirze-Pep 5 mg review.
Drug Class: Recombinant Human Growth Hormone (rHGH)
Composition: Somatropin 191aa
Dosage: 10 IU/vial
Form: Lyophilized Powder
Unit: 1 Kit (10 x 2 mL Vials)
Brand: Dragon Pharma
Laboratory Test: View Latest Lab Report
For Injectable Use After Reconstitution
Drug Class: Gonadotropin, Fertility Agent
Composition: Human Chorionic Gonadotropin (HCG)
Dosage: 2500 IU/vial
Form: Lyophilized Powder
Unit: 2 mL Multidose Vial + 1 Amp Solvent
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Injectable Use After Reconstitution
Drug Class: Synthetic Peptide (Thymosin Beta-4)
Composition: Thymosin Beta-4
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Subcutaneous Injection After Reconstitution
Drug Class: Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist
Composition: Semaglutide
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Subcutaneous Injection After Reconstitution
Drug Class: Gonadotropin, Fertility Agent, LH Analog
Composition: Human Chorionic Gonadotropin
Dosage: 5000 IUs/vial
Form: Lyophilized Powder
Unit: 2 mL Vial + 1 Amp Solvent
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Subcutaneous Injection
Drug Class: Synthetic Melanocortin Agonist Peptide
Composition: Melanotan II
Dosage: 10 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Injectable Use After Reconstitution
Drug Class: Anxiolytic Nootropic Peptide
Composition: Selank
Dosage: 10 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Injectable & Intranasal Use After Reconstitution
Drug Class: Growth Hormone Releasing Peptide (GHRP)
Composition: Ipamorelin (Pentapeptide)
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Injectable Use After Reconstitution
September 13, 2024
I've been on Dragozepide from Dragon Pharma for three months now, and I couldn't be happier. My blood sugar is better than ever, and I'm consistently losing weight. The quality and efficacy of this product are impressive.